EUVIMEDEUVIMED entdecken
Crossref

Biomimetic Engineering of Hybrid Radiosensitizers to Boost Radiotherapy against Cancer Metastasis

Huandong Xiang, Xin Li, Haoran Wei, Xu Zu, Yilong Wan, Zan Cheng, Tianjiao Mao, Yu Xiao, Genxing Ren, Jinyang Lu, Ping Fan, Hui Yuan und 4 weitere

Advanced Materials · 2025

DOI: 10.1002/adma.202501077 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Materials, 2025. Verfasst von Huandong Xiang und 15 weiteren Autor:innen. Beteiligte Einrichtung: School of Biomedical Sciences and Engineering, South China University of Technology, Guangzhou International Campus, Guangzhou, 511442, P. R. China. Hauptthemen laut MEDLINE: Radiation-Sensitizing Agents, Biomimetic Materials, Biomimetics. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 73 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Over the past 120 years, significant efforts are dedicated to delivering maximum radiation doses to tumor sites while sparing adjacent normal tissues as much as possible. Despite encouraging progress in the development of heavy metal‐based nanoscale radiosensitizers, radiotherapy often fails to fully eradicate hypoxic tumors, leading to local recurrence or even progression to distant metastasis. In this study, a versatile biomimetic hybrid radiosensitizer is engineered by integrating the hypoxia‐activated prodrug banoxantrone and CeO 2 nanozymes into mesoporous silica‐coated Bi 2 O 3 nanoparticles (NPs), followed by camouflage coating with cancer‐cell‐derived membranes. Compared to naked Bi 2 O 3 NPs and free banoxantrone alone, the radiosensitization efficacy of the biomimetic NPs is substantially enhanced toward both normoxic and hypoxic cancer cells. Moreover, lung metastasis is markedly inhibited by reactive oxygen species‐mediated remodeling of the extracellular matrix through the activity of CeO 2 nanozymes. As confirmed by in vitro and in vivo results, the biomimetic hybrid radiosensitizer enhances radiotherapy against lung metastasis with fewer side effects. This study provides compelling evidence for the development of next‐generation radiosensitizers with optimized functionalities using biomimetic hybrid engineering to finely balance the benefits and risks of radiotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Radiation-Sensitizing AgentsBiomimetic MaterialsBiomimeticsAnimalsHumansCeriumCell Line, TumorMiceLung NeoplasmsNanoparticlesBismuthSilicon DioxideNeoplasm MetastasisReactive Oxygen SpeciesProdrugs

Stichwörter der Autor:innen

biomimetic engineeringcancer metastasishybrid nanomaterialsradiosensitizationradiotherapy

Substanzen

Radiation-Sensitizing AgentsCeriumceric oxideBismuthSilicon DioxideReactive Oxygen SpeciesProdrugs

Autor:innen und Institutionen

  • School of Biomedical Sciences and Engineering, South China University of Technology, Guangzhou International Campus, Guangzhou, 511442, P. R. China.
  • CAS Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing, 100049, P. R. China.
  • CAS Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology, Beijing, 100190, China.
  • School of Nanoscience and Nanotechnology, University of Chinese Academy of Sciences, Beijing, 100049, China.
  • College of Chemistry and Materials Science, and Institute of Nanotechnology And Intelligence (INAI), Jinan University, Guangzhou, 510632, China.

ORCID-Profile: Liang Yan

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Xiang, H., Li, X., Wei, H., Zu, X., Wan, Y., Cheng, Z., Mao, T., Xiao, Y., Ren, G., Lu, J., Fan, P., Yuan, H., Xiong, M., Meng, H., Yan, L., & Zhao, Y. (2025). Biomimetic Engineering of Hybrid Radiosensitizers to Boost Radiotherapy against Cancer Metastasis. Advanced Materials. https://doi.org/10.1002/adma.202501077

Vancouver

Xiang H, Li X, Wei H, Zu X, Wan Y, Cheng Z, et al. Biomimetic Engineering of Hybrid Radiosensitizers to Boost Radiotherapy against Cancer Metastasis. Advanced Materials. 2025. doi:10.1002/adma.202501077

BibTeX
@article{Xiang2025,
  author = {Xiang, Huandong and Li, Xin and Wei, Haoran and Zu, Xu and Wan, Yilong and Cheng, Zan and Mao, Tianjiao and Xiao, Yu and Ren, Genxing and Lu, Jinyang and Fan, Ping and Yuan, Hui and Xiong, Menghua and Meng, Huan and Yan, Liang and Zhao, Yuliang},
  title = {Biomimetic Engineering of Hybrid Radiosensitizers to Boost Radiotherapy against Cancer Metastasis},
  journal = {Advanced Materials},
  year = {2025},
  doi = {10.1002/adma.202501077}
}
Kostenlos starten →